Basic Components of Connective Tissues and Extracellular Matrix: Elastin, Fibrillin, Fibulins, Fibrinogen, Fibronectin, Laminin, Tenascins and Thrombospondins

被引:356
作者
Halper, Jaroslava [1 ]
Kjaer, Michael [2 ,3 ]
机构
[1] Univ Georgia, Coll Vet Med & Med Partnership, Dept Pathol, Athens, GA 30602 USA
[2] Bispebjerg Hosp, Inst Sports Med, DK-2400 Copenhagen, Denmark
[3] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Hlth Aging, Copenhagen, Denmark
来源
PROGRESS IN HERITABLE SOFT CONNECTIVE TISSUE DISEASES | 2014年 / 802卷
关键词
Elastin; Fibrillin; Fibulins; Laminin; Tenascins; PETERS-PLUS SYNDROME; EPIDERMAL-CELL MIGRATION; DE-NOVO SYNTHESIS; GROWTH-FACTOR; TGF-BETA; AMINE OXIDASE; PROTEIN COMP; FUNCTIONAL-PROPERTIES; CONGENITAL DISORDER; GENE-EXPRESSION;
D O I
10.1007/978-94-007-7893-1_3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Collagens are the most abundant components of the extracellular matrix and many types of soft tissues. Elastin is another major component of certain soft tissues, such as arterial walls and ligaments. Many other molecules, though lower in quantity, function as essential components of the extracellular matrix in soft tissues. Some of these are reviewed in this chapter. Besides their basic structure, biochemistry and physiology, their roles in disorders of soft tissues are discussed only briefly as most chapters in this volume deal with relevant individual compounds. Fibronectin with its muldomain structure plays a role of "master organizer" in matrix assembly as it forms a bridge between cell surface receptors, e. g., integrins, and compounds such collagen, proteoglycans and other focal adhesion molecules. It also plays an essential role in the assembly of fibrillin-1 into a structured network. Laminins contribute to the structure of the extracellular matrix (ECM) and modulate cellular functions such as adhesion, differentiation, migration, stability of phenotype, and resistance towards apoptosis. Though the primary role of fibrinogen is in clot formation, after conversion to fibrin by thrombin, it also binds to a variety of compounds, particularly to various growth factors, and as such fibrinogen is a player in cardiovascular and extracellular matrix physiology. Elastin, an insoluble polymer of the monomeric soluble precursor tropoelastin, is the main component of elastic fibers in matrix tissue where it provides elastic recoil and resilience to a variety of connective tissues, e. g., aorta and ligaments. Elastic fibers regulate activity of TGF beta s through their association with fibrillin microfibrils. Elastin also plays a role in cell adhesion, cell migration, and has the ability to participate in cell signaling. Mutations in the elastin gene lead to cutis laxa. Fibrillins represent the predominant core of the microfibrils in elastic as well as non-elastic extracellular matrixes, and interact closely with tropoelastin and integrins. Not only do microfibrils provide structural integrity of specific organ systems, but they also provide a scaffold for elastogenesis in elastic tissues. Fibrillin is important for the assembly of elastin into elastic fibers. Mutations in the fibrillin-1 gene are closely associated with Marfan syndrome. Fibulins are tightly connected with basement membranes, elastic fibers and other components of extracellular matrix and participate in formation of elastic fibers. Tenascins are ECM polymorphic glycoproteins found in many connective tissues in the body. Their expression is regulated by mechanical stress both during development and in adulthood. Tenascins mediate both inflammatory and fibrotic processes to enable effective tissue repair and play roles in pathogenesis of Ehlers-Danlos, heart disease, and regeneration and recovery of musculo-tendinous tissue. One of the roles of thrombospondin 1 is activation of TGF beta. Increased expression of thrombospondin and TGF beta activity was observed in fibrotic skin disorders such as keloids and scleroderma. Cartilage oligomeric matrix protein (COMP) or thrombospondin-5 is primarily present in the cartilage. High levels of COMP are present in fibrotic scars and systemic sclerosis of the skin, and in tendon, especially with physical activity, loading and post-injury. It plays a role in vascular wall remodeling and has been found in atherosclerotic plaques as well.
引用
收藏
页码:31 / 47
页数:17
相关论文
共 144 条
[41]   Ageing of the conduit arteries [J].
Greenwald, S. E. .
JOURNAL OF PATHOLOGY, 2007, 211 (02) :157-172
[42]   Strength at the extracellular matrix-muscle interface [J].
Grounds, MD ;
Sorokin, L ;
White, J .
SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS, 2005, 15 (06) :381-391
[43]   Tenascin-Y: A protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue [J].
Hagios, C ;
Koch, M ;
Spring, J ;
Chiquet, M ;
ChiquetEhrismann, R .
JOURNAL OF CELL BIOLOGY, 1996, 134 (06) :1499-1512
[44]   COMP acts as a catalyst in collagen fibrillogenesis [J].
Halasz, Krisztina ;
Kassner, Anja ;
Morgelin, Matthias ;
Heinegard, Dick .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (43) :31166-31173
[45]   Structural and functional properties of the human Notch-1 ligand binding region [J].
Hambleton, S ;
Valeyev, NV ;
Muranyi, A ;
Knott, V ;
Werner, JM ;
McMichael, AJ ;
Handford, PA ;
Downing, AK .
STRUCTURE, 2004, 12 (12) :2173-2183
[46]   Atypical Peters plus syndrome with new associations [J].
Hanna, Nancy N. ;
Eickholt, Kimberly ;
Agamanolis, Dimitri ;
Burnstine, Robert ;
Edward, Deepak P. .
JOURNAL OF AAPOS, 2010, 14 (02) :181-183
[47]   Proteoglycans and more - from molecules to biology [J].
Heinegard, Dick .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2009, 90 (06) :575-586
[48]   Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the 1,3-glucosyltransferase that modifies thrombospondin type 1 repeats [J].
Heinonen, Taisto Y. K. ;
Maki, Markku .
ANNALS OF MEDICINE, 2009, 41 (01) :2-10
[49]   Peters plus syndrome is a new congenital disorder of glycosylation and involves defective O-glycosylation of thrombospondin type 1 repeats [J].
Hess, Daniel ;
Keusch, Jeremy J. ;
Oberstein, Saskia A. Lesnik ;
Hennekam, Raoul C. M. ;
Hofsteenge, Jan .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (12) :7354-7360
[50]   COMP:: a candidate molecule in the pathogenesis of systemic sclerosis with a potential as a disease marker [J].
Hesselstrand, R. ;
Kassner, A. ;
Heinegard, D. ;
Saxne, T. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (09) :1242-1248